HIF1A and breast carcinoma: HIF-1α also activates miR-210 [57]; in human breast cancer cells, over-expression of hsa-miR-210 is induced by hypoxia, dependent on the function of HIF-1α and VHL (von Hippel-Lindau syndrome protein, involved in the ubiquitylation and degradation of HIF) [58].